According to the Phase 2 of clinical trial, Nilotinib (Brand Tasigna) manufactured by Novartis can help in modulating the metabolism and level of dopamine in the body. Formation of toxic-alpha synuclein aggregates can also be prevented with the help Nilotinib (generic of Tasigna) treatment.
Listbookmarking.com is your go-to platform for organizing and managing your favorite online content. Our website allows you to easily save, categorize, and share links to articles, videos, and websites that matter to you. With intuitive tools and customizable folders, you can keep your digital life organized and accessible from any device
